Non-Hodgkin lymphoma: Excellent results at the expense of the high toxicity of the treatment
Authors:
- M.A. Baena-GómezMBM.A. Baena-Gómez
- M. Mora MatillaMMM. Mora Matilla
- A. Lassaletta AtienzaAAA. Lassaletta Atienza
- M. Andión CatalánMCM. Andión Catalán
- C. Hernández MarquésCMC. Hernández Marqués
- L. Madero LópezLLL. Madero López
- 1 June 2015
- journal article
- Published by Elsevier in Anales de Pediatría (English Edition)
- Vol. 82 (6) , 381-387
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Children With Cancer and HIV InfectionJournal of Pediatric Hematology/Oncology, 2013
- Mature B-Cell Lymphoma and Leukemia in Children and Adolescents—Review of Standard Chemotherapy Regimen and PerspectivesPediatric Hematology and Oncology, 2013
- Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profilingBlood, 2012
- Burkitt's lymphomaThe Lancet, 2012
- Treatment outcomes in children with Burkitt lymphoma and L3 acute lymphoblastic leukemia treated using the lymphoma malignancy B protocol at a single institutionThe Korean Journal of Hematology, 2011
- The contribution of the Epstein-Barr virus to the pathogenesis of childhood lymphomasCancer Treatment Reviews, 2010
- Epidemiology of childhood cancerCancer Treatment Reviews, 2010
- Pediatric lymphomas in BrazilClinics, 2010
- Sporadic childhood Burkitt lymphoma incidence in the United States during 1992–2005Pediatric Blood & Cancer, 2009
- Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001Blood, 2006